Customer Testimonials at Quotient Sciences

Drug Development Workshop and Cocktail Making Class

London (King's Cross/St. Pancras), United Kingdom | 21 March 2024

At Quotient, we strive to deliver a full-service drug development offering that meets the needs of the industry and our customers. The purpose of this event is to connect with you to ensure that we are aligned and aware of the challenges that you are facing and to get your input on the needs, drivers and service gaps that exist in the CDMO/CRO sector to better support you.

This interactive session will be driven by a number of our specialists in the field and other likeminded individuals within the industry looking to accelerate their molecules to the marketplace. After Lunch we have booked a cocktail making class to round up the day.

If this is something that you would be interested in participating in, please register using the link below as soon as possible so we can reserve your seat. Feel free to reach out to Abi Lynch directly at with any additional questions.



Agenda - March 21, 2024Location
Arrival – 1-1:30 PM
Drug Development Workshop & Lunch – 1:30-3 PM
Cocktail Making Session – 3-5 PM
Drake & Morgan
6 Pancras Square
London, N1C 4AG

We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Drake & Morgan
6 Pancras Square
London (King's Cross/St. Pancras), United Kingdom

Meet our expert:

We look forward to meeting you at our Drug Development Workshop in London.

Charlotte Hannigan

Associate Director, Business Development

With a chemistry background, I have technical and commercial experience in the pharmaceutical industry, spanning a range of discip...

About Charlotte

More insight from our experts:

Read More
Oncology, Translational Pharmaceutics, Dr. Paul Quigley Insight from our experts: How Translational Pharmaceutics accelerates oncology clinical trials By: Dr. Paul Quigley
Read More
Oncology, Translational Pharmaceutics, John McDermott A Smarter Strategy for Optimizing Oncology Drug Products By: John McDermott
Read More